Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing VANCOUVER, Feb. 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 23, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ,...
Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN,...
Khiron Signs Letter of Intent to Acquire Colombia’s Leading Health Network Acquisition to deliver network of 100,000 patients that meet Khiron’s indicated targets TORONTO, Aug. 7, 2018 /CNW/ –...
Increased capacity to meet market demand and advance the Company’s objective of addressing the medical needs of 1 million patients in Latin America TORONTO, Aug. 2, 2018 /CNW/ – Khiron Life Sciences Corp....
Appointment expands business and political network and furthers development of medical cannabis education and research across Latin America TORONTO, July 17, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron”...
TORONTO, June 26, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Medical Cannabis, Pain and Palliative Care Physician/Researcher will oversee Khiron’s product development and physician’s educational program TORONTO, June 25, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the...
President-Elect’s platform promises significant economic measures to increase foreign investment and international trade TORONTO, June 21, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN),...
Former DEA Chief of Pharmaceutical Investigations leading Khiron’s best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated medical...
Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients Demonstrates scalability and recurring revenue potential in the Colombian and Latin American markets TORONTO, June...
Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia Colombian Agricultural Institute (“ICA”) authorization is a significant requirement to...
The Colombian Association of Internal Medicine and the Colombian Association of Neurology agree to support Khiron’s development of medical cannabis education, research and professional programs for nearly 3,000 doctors...
Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...
Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
TORONTO, May 29, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the Company is...
Khiron to Commence Trading on TSX Venture Exchange — First Canadian Cannabis Company with Core Operations in Colombia to List on Any Exchange Globally — — Khiron to Host...
Adent and Khiron Announce Closing of Subscription Receipt Financing TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — Further to the press releases dated November 7, 2017, and December 27, 2017,...
Adent and Khiron Announce $6M Subscription Receipt Financing in Connection With the Business Combination TORONTO, Nov. 7, 2017 /CNW/ – Adent Capital Corp. (“Adent”) (NEX: ANT.H) and Khiron Life...
Exclusive Interview with Khiron Life Sciences CEO Alvaro Torres Colombia is a developing cannabis market that has captured the attention of many. A country known historically for being a...
Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia TORONTO, Sept. 26, 2017 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports...
